Tag: AbbVie Inc

Browse exclusive Tags!

AbbVie to Acquire ImmunoGen for $10.1B, Bringing Elahere Cancer Drug to Market, US

AbbVie acquires ImmunoGen for $10.1B, gaining access to cancer drug Elahere and solidifying its position in tumor treatment. Exciting news for the biotech industry.

Popular

Subscribe

spot_imgspot_img